<DOC>
	<DOCNO>NCT02889965</DOCNO>
	<brief_summary>OFSEP observational cohort Multiple Sclerosis ( MS ) relate disorder set France . It aim provide major epidemiological tool MS scientific community France abroad . This tool must help answer large number question concern cause mechanisms MS , prognostic factor disease progression , effectiveness safety therapeutic drug , impact disease patient society , etc . In December 2015 , already include 54.000 patient . To achieve goal , OFSEP 's objective - To maintain develop French cohort patient suffer MS related disease syndromes . This mean collect standardize socio-demographic clinical data part routine medical follow-up patient already cohort recruitment new patient . - To supplement exist clinical data standardize quality biological sample MRI scan . - To improve previous data medical/administrative data health insurance fund databases particular , order get information comorbidity , treatment protocol medico-economic aspect disease . - To use OFSEP infrastructure facilitate implementation specific study require collection additional data specific patient monitoring process . - To ensure availability data sample researcher , health care authority industrial player enable analysis thus provide answer research question public health issue . This availability possible scientific regulatory evaluation request . - To provide regular description patient population cohort offer statistic , target up-to-date information disease thus enable good approach personal , professional social impact illness , effect basic treatment requirement related follow-up disease France . - To conduct specific study entire population patient cohort ( parent cohort ) patient sub-groups specific characteristic ( nested cohort ) . Four nested cohort define : patient radiologically isolated syndrome , patient clinically isolated syndrome , patient primary progressive course disease patient neuromyelitis optica ( Devic 's syndrome ) spectrum disorder .</brief_summary>
	<brief_title>The French Multiple Sclerosis Registry</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Neuromyelitis Optica</mesh_term>
	<criteria>RIS CIS MS accord McDonald 2010 criterion NMOSD others per NOMADMUS criteria No age limt All clinical course Domiciliated France Signed OFSEP inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>Pharmacoepidemiology</keyword>
	<keyword>Disease modifying drug</keyword>
	<keyword>Neuro-myelitis optica</keyword>
</DOC>